T cell responses to viral infections: Lessons from lymphocytic choriomeningitis virus

Immunologic Research

Volumn 26, Issue 1-3, 2002, Pages 309-321

  Khanolkar, Aaruni ^a   Fuller, Michael J ^a   Zajac, Allan J ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Cytokines; Persistence; T cells; Tetramers; Viral infection

Indexed keywords

CD8 ANTIGEN; CYTOKINE;

ARTICLE; CELL KILLING; DISEASE ASSOCIATION; GENE DELETION; IMMUNE RESPONSE; IMMUNE SYSTEM; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS CELL INTERACTION; VIRUS INFECTION; VIRUS REPLICATION;

ACUTE DISEASE; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CHRONIC DISEASE; LYMPHOCYTE ACTIVATION; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE;

EID: 0036395950     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1385/IR:26:1-3:309     Document Type: Article

References (56)

1. Whitton JL, Oldstone MBA: The immune response to viruses; in Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B (eds): Fundamental Virology. Philadelphia, Lippincott Williams & Wilkins, 2001, pp. 285-320.
2. Ahmed R, Morrison LA, Knipe DM: Viral persistence; in Nathanson N, Ahmed R, Gonzalez-Scarano F, Griffin DE, Holmes KV, Murphy FA, Robinson HL (eds): Viral Pathogenesis. Philadelphia, Lippincott-Raven, 1997, pp. 181-205.
3. Harty JT, Tvinnereim AR, White DW: CD8+ T cell effector mechanisms in resistance to infection. Annu Rev Immunol 2000;18:275-308.
4. Guidotti LG, Chisari FV: Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol 2001;19:65-91.
5. Zajac AJ, Blattman JN, Murali-Krishna K, Sourdive DJ, Suresh M, Altman JD, Ahmed R: Viral immune evasion due to persistence of activated T cells without effector function. J Exp Med 1998;188:2205-2213.
6. Kalams SA, Walker BD: The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses. J Exp Med 1998;188:2199-2204.
7. Borrow P, Oldstone MBA: Lymphocytic choriomeningitis virus; in Nathanson N, Ahmed R, Gonzalez-Scarano F, Griffin DE, Holmes KV, Murphy FA, Robinson HL (eds): Viral Pathogenesis. Philadelphia, Lippincott-Raven, 1997, pp. 593-627.
8. Buchmeier MJ, Zajac AJ: Lymphocytic choriomeningitis virus; in Ahmed R, Chen ISY (eds): Persistent Viral Infections. Chichester, West Sussex, John Wiley & Sons 1999, pp. 575-605.
9. Welsh RM: Lymphocytic choriomeningitis virus as a model for the study of cellular immunology; in Cunningham MW, Fujinami RS (eds): Effects of Microbes on the Immune System. Philadelphia, Lippincott Williams & Wilkins, 2000, pp. 289-312.
10. Butz EA, Bevan MJ: Massive expansion of antigen-specific CD8+ T cells during an acute virus infection. Immunity 1998;8:167-175.
11. Murali-Krishna K, Altman JD, Suresh M, Sourdive DJ, Zajac AJ, Miller JD, Slansky J, Ahmed R: Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 1998;8:177-187.
12. Bachmann MF: Evaluation of lymphocytic choriomeningitis virus-specific cytotoxic T cell responses; in Lefkovits I (ed): Immunology Methods Manual. San Diego, Academic, 1997, pp. 1919-1933.
13. Altman JD, Moss PA, Goulder PJ, Barouch DH, McHeyzer-Williams MG, Bell JI, McMichael AJ, Davis MM: Phenotypic analysis of antigen-specific T lymphocytes. Science 1996;274:94-96.
14. Lin MY, Welsh RM: Stability and diversity of T cell receptor repertoire usage during lymphocytic choriomeningitis virus infection of mice. J Exp Med 1998;188:1993-2005.
15. Blattman JN, Sourdive DJ, Murali-Krishna K, Ahmed R, Altman JD: Evolution of the T cell repertoire during primary, memory, and recall responses to viral infection. J Immunol 2000;165:6081-6090.
16. Homann D, Teyton L, Oldstone MB: Differential regulation of antiviral T-cell immunity results in stable CD8+ but declining CD4+ T-cell memory. Nat Med 2001;7:913-919.
17. Hudrisier D, Oldstone MB, Gairin JE: The signal sequence of lymphocytic choriomeningitis virus contains an immunodominant cytotoxic T cell epitope that is restricted by both H-2D(b) and H-2K(b) molecules. Virology 1997;234:62-73.
18. Flynn KJ, Belz GT, Altman JD, Ahmed R, Woodland DL, Doherty PC: Virus-specific CD8+ T cells in primary and secondary influenza pneumonia. Immunity 1998;8:683-691.
19. Chang J, Braciale TJ: Respiratory syncytial virus infection suppresses lung CD8+ T-cell effector activity and peripheral CD8+T-cell memory in the respiratory tract. Nat Med 2002;8:54-60.
20. Stevenson PG, Belz GT, Altman JD, Doherty PC: Virus-specific CD8+ T cell numbers are maintained during gamma-herpesvirus reactivation in CD4-deficient mice. Proc Natl Acad Sci USA 1998;95:15,565-15,570.
21. Doherty PC, Christensen JP: Accessing complexity: the dynamics of virus-specific T cell responses. Annu Rev Immunol 2000;18:561-592.
22. Callan MF, Tan L, Annels N, Ogg GS, Wilson JD, O'Callaghan CA, Steven N, McMichael AJ, Rickinson AB: Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus In vivo. J Exp Med 1998;187:1395-1402.
23. Rickinson AB, Moss DJ: Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. Annu Rev Immunol 1997;15:405-431.
24. Rooney CM, Smith CA, Ng CY, Loftin S, Li C, Krance RA, Brenner MK, Heslop HE: Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation. Lancet 1995;345:9-13.
25. Papadopoulos EB, Ladanyi M, Emanuel D, et al: Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N Engl J Med 1994;330:1185-1191.
26. Ogg GS, Jin X, Bonhoeffer S, et al: Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 1998;279:2103-2106.
27. Pantaleo G, Demarest JF, Soudeyns H, Graziosi C, Denis F, Adelsberger JW, Borrow P, Saag MS, Shaw GM, Sekaly RP, Fauci, AS: Major expansion of CD8+ T cells with a predominant V beta usage during the primary immune response to HIV. Nature 1994;370:463-467.
28. Schmitz JE, Kuroda MJ, Santra S, et al: Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 1999;283:857-860.
29. Jin X, Bauer DE, Tuttleton SE, Lewin S, Gettie A, Blanchard J, Irwin CE, Safrit JT, Mittler J, Weinberger L, Kostrikis LG, Zhang L, Perelson AS, Ho DD: Dramatic rise in plasma viremia after CD8+ T cell depletion in simian immunodeficiency virus-infected macaques. J Exp Med 1999;189:991-998.
30. He XS, Rehermann B, Lopez-Labrador FX, Boisvert J, Cheung R, Mumm J, Wedemeyer H, Berenguer M, Wright TL, Davis MM, Greenberg HB: Quantitative analysis of hepatitis C virus-specific CD8+ T cells in peripheral blood and liver using peptide-MHC tetramers. Proc Natl Acad Sci USA 1999;96:5692-5697.
31. Lechner F, Wong DK, Dunbar PR, Chapman R, Chung RT, Dohrenwend P, Robbins G, Phillips R, Klenerman P, Walker BD: Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med 2000;191:1499-1512.
32. Varga SM, Welsh RM: Cutting edge: detection of a high frequency of virus-specific CD4+ T cells during acute infection with lymphocytic choriomeningitis virus. J Immunol 1998;161:3215-3218.
33. Whitmire JK, Asano MS, Murali-Krishna K, Suresh M, Ahmed R: Long-term CD4 Th1 and Th2 memory following acute lymphocytic choriomeningitis virus infection. J Virol 1998;72:8281-8288.
34. Kamperschroer C, Quinn DG: Quantification of epitope-specific MHC class-II-restricted T cells following lymphocytic choriomeningitis virus infection. Cell Immunol 1999;193:134-146.
35. von Herrath MG, Yokoyama M, Dockter J, Oldstone MB, Whitton JL: CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge. J Virol 1996;70:1072-1079.
36. Oxenius A, Zinkernagel RM, Hengartner H: CD4+ T-cell induction and effector functions: a comparison of immunity against soluble antigens and viral infections. Adv Immunol 1998;70:313-367.
37. Matloubian M, Kolhekar SR, Somasundaram T, Ahmed R: Molecular determinants of macrophage tropism and viral persistence: importance of single amino acid changes in the polymerase and glycoprotein of lymphocytic choriomeningitis virus. J Virol 1993;67:7340-7349.
38. Evans CF, Borrow P, de la Torre JC, Oldstone MB: Virus-induced immunosuppression: kinetic analysis of the selection of a mutation associated with viral persistence. J Virol 1994;68:7367-7373.
39. Cao W, Henry MD, Borrow P, Yamada H, Elder JH, Ravkov EV, Nichol ST, Compans RW, Campbell KP, Oldstone MB: Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus. Science 1998;282:2079-2081.
40. Sevilla N, Kunz S, Holz A, Lewicki H, Homann D, Yamada H, Campbell KP. de La Torre JC, Oldstone MB: Immunosuppression and resultant viral persistence by specific viral targeting of dendritic cells. J Exp Med 2000;192:1249-1260.
41. Gallimore A, Glithero A, Godkin A, Tissot AC, Pluckthun A, Elliott T, Hengartner H, Zinkernagel R: Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes. J Exp Med 1998;187:1383-1393.
42. Pantaleo G, Soudeyns H, Demarest JF, Vaccarezza M, Graziosi C, Paolucci S, Daucher M, Cohen OJ, Denis F, Biddison WE, Sekaly RP, Fauci AS: Evidence for rapid disappearance of initially expanded HIV-specific CD8+ T cell clones during primary HIV infection. Proc Natl Acad Sci USA 1997;94:9848-9853.
43. Goulder PJ, Altfeld MA, Rosenberg ES, et al: Substantial differences in specificity of HIV-specific cytotoxic T cells in acute and chronic HIV infection. J Exp Med 2001;193:181-194.
44. Champagne P, Ogg GS, King AS, et al: Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 2001;410:106-111.
45. Appay V, Nixon DF, Donahoe SM, et al: HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function. J Exp Med 2000;192:63-75.
46. Gea-Banacloche JC, Migueles SA, Martino L, et al: Maintenance of large numbers of virus-specific CD8+ T cells in HIV-infected progressors and long-term nonprogressors. J Immunol 2000;165:1082-1092.
47. Goepfert PA, Bansal A, Edwards BH, Ritter GD Jr, Tellez I, McPherson SA, Sabbaj S, Mulligan MJ: A significant number of human immunodeficiency virus epitope-specific cytotoxic T lymphocytes detected by tetramer binding do not produce gamma interferon. J Virol 2000;74:10,249-10,255.
48. Gruener NH, Lechner F, Jung MC, Diepolder H, Gerlach T, Lauer G, Walker B, Sullivan J, Phillips R, Pape GR, Klenerman P: Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis C virus. J Virol 2001;75:5550-5558.
49. Moser JM, Altman JD, Lukacher AE: Antiviral CD8+ T cell responses in neonatal mice: susceptibility to polyoma virus-induced tumors is associated with lack of cytotoxic function by viral antigen-specific T cells. J Exp Med 2001;193:595-606.
50. Lee PP, Yee C, Savage PA, Fong L, Brockstedt D, Weber JS, Johnson D, Swetter S, Thompson J, Greenberg PD, Roederer M, Davis MM: Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients. Nat Med 1999;5:677-685.
51. Zajac AJ, Murali-Krishna K, Blattman JN, Ahmed R: Therapeutic vaccination against chronic viral infection: the importance of cooperation between CD4+ and CD8+ T cells. Curr Opin Immunol 1998;10:444-449.
52. Rosenberg ES, Billingsley JM, Caliendo AM, Boswell SL, Sax PE, Kalams SA, Walker BD: Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science 1997;278:1447-1450.
53. Spiegel HM, Ogg GS, DeFalcon E, Sheehy ME, Monard S, Haslett PA, Gillespie G, Donahoe SM, Pollack H, Borkowsky W, McMichael AJ, Nixon DF: Human immuno-deficiency virus type 1- and cytomegalovirus-specific cytotoxic T lymphocytes can persist at high frequency for prolonged periods in the absence of circulating peripheral CD4(+) T cells. J Virol 2000;74:1018-1022.
54. Hazenberg MD, Hamann D, Schuitemaker H, Miedema F: T cell depletion in HIV-1 infection: how CD4+ T cells go out of stock. Nat Immunol 2000;1:285-289.
55. Rosenberg ES, Altfeld M, Poon SH, Phillips MN, Wilkes BM, Eldridge RL, Robbins GK, D'Aquila RT, Goulder PJ, Walker BD: Immune control of HIV-1 after early treatment of acute infection. Nature 2000;407:523-526.
56. Walter EA, Greenberg PD, Gilbert MJ, Finch RJ, Watanabe KS, Thomas ED, Riddell SR: Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med 1995;333:1038-1044.